Journal article

Venetoclax: a primer

Andrew W Roberts

Blood Advances | AMER SOC HEMATOLOGY | Published : 2017

University of Melbourne Researchers


Funding Acknowledgements

A.W.R. received research funding from AbbVie and Genentech, the codevelopers of venetoclax; and is an employee of the Walter and Eliza Hall Institute of Medical Research, which receives royalty income related to venetoclax. A.W.R. has no personal financial interest in venetoclax. He has also received research funding from Janssen and Servier.